Clareon® TruPlus
Monofocal and Toric IOL
Clareon® TruPlus
Monofocal and Toric IOL
Providing slightly more depth of focus, without
compromising the distance you expect.
Clareon® TruPlus is Alcon's enhanced monofocal and toric IOL, powered by proprietary Opti-Balance, designed to deliver a
slight depth of focus extension, in addition to outstanding distance vision.
Clareon® TruPlus is designed for:
Extended Depth of Focus1,2
~3.5 letters improved simulated VA at 66 cm*†
High-Quality Distance1,2,5†
Exceeds ISO upper requirement at 3 mm aperture†
Low Halo & Glare Profile9,10†
Fully usable 6 mm optic†
Exceptional Stability11,16
STABLEFORCE® Haptics provide exceptional axial stability for a range of capsule sizes‡
*vs. Clareon Monofocal
†Based on bench data.
‡In vitro measurement of axial displacement at compression diameters 11.0, 10.5, 10.0, 9.5, and 9.0mm for Clareon SY60WF, AcrySof SN60WF.
Trademarks are the property of their respective owners.
The Clareon® Collection - More Options for More Patients
Clareon® TruPlus joins a portfolio that gives surgeons answers for different cataract patient profiles
Clareon® Monofocal and Toric
Flagship monofocal/toric for outstanding, predictable distance vision
Clareon® Vivity®
Clareon monofocal IOL provides excellent distance and functional intermediate vision
Clareon® PanOptix® Pro
The next generation of PanOptix innovation - a full range of vision, with half the light scatter*†
*PanOptix has 88% light utilization (12% scatter light)/PanOptix Pro 94% light utilization (6% scatter light). †Based on manufacturer reported values and respective methodology for Clareon PanOptix, Envista Envy, AT Elana, Gemetric and Rayner.
Looking for information for patients
or caregivers?
Important Product Information – Clareon® Aspheric Family of Hydrophobic Acrylic IOLs with the AutonoMe® Automated Pre-loaded Delivery System
CAUTION: Federal law restricts this device to sale by or on the order of a physician.
INDICATIONS:The Clareon® Aspheric Hydrophobic Acrylic IOLs include the Clareon® Aspheric and Clareon® Aspheric Toric IOLs and are indicated for primary implantation in the capsular bag in the posterior chamber of the eye for the visual correction of aphakia in adult patients in whom a cataractous lens has been removed. In addition, the Clareon® Aspheric Toric IOL is indicated to correct pre-existing corneal astigmatism.
WARNINGS / PRECAUTIONS: The Clareon® IOL is intended for implantation in the capsular bag only. Physicians considering lens implantation under any of the following circumstances should weigh the potential risk/benefit ratio: Patients in whom the posterior capsule is ruptured, zonules are damaged, or primary posterior capsulotomy is planned.
Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting the IOL in a patient with any of the conditions described in the Directions for Use.
For the Clareon® Aspheric Toric IOLs, rotation can reduce astigmatic correction; if necessary lens repositioning should occur as early as possible prior to lens encapsulation.
As with any surgical procedure, there is risk involved. Potential complications accompanying cataract and/or IOL implantation surgery may include, but are not limited to, the following: lens epithelial cell on- growth, corneal endothelial cell damage, infection (endophthalmitis), toxic anterior segment syndrome (TASS), retinal detachment, vitritis, cystoid macular edema, corneal edema, pupillary block, cyclitic membrane, iris prolapse, hypopyon, anterior uveitis, hyphema, pigment dispersion, posterior capsule opacification, transient or persistent glaucoma, and secondary surgical interventions. Secondary surgical interventions include, but are not limited to: lens repositioning, lens replacement, vitreous aspiration or iridectomy for pupillary block, wound leak repair, and retinal detachment repair.
Prior to surgery, prospective patients should be informed of the possible risks and benefits associated with this IOL as well as the risks and benefits associated with cataract surgery. After surgery, physicians should provide an implant card to patients regarding the IOL implanted.
DO NOT re-sterilize the Clareon® IOL or the AutonoMe® Delivery System by any method. The device is for single use only.
ATTENTION: Reference the Directions for Use labeling for each IOL for a complete listing of indications, warnings and precautions.
REFERENCES:
- Alcon data on file, 2025. REF-28331.
- Alcon data on file, 2025. REF-28335.
- Alcon data on file, 2025. REF-28336.
- Micheletti JM, Duncan NB, Hall B. Head-to-Head Comparison of Intermediate Vision of Two Monofocal Intraocular Lenses. Clinical Ophthalmology. 2023 Dec 31:3983-90.
- Alcon data on file, 2025. REF-28362.
- Alcon data on file, 2025. REF-29104.
- Alcon data on file, 2025. REF-29105.
- Alcon data on file, 2025. REF-28847.
- Alcon data on file, 2025. REF-28549.
- Alcon data on file, 2025. REF-28699.
- Alcon data on file, 2025. REF-28698.
- Ribeiro et al. Evidence-based functional classification of simultaneous vision intraocular lenses: seeking a global consensus by the ESCRS Functional Vision Working Group. J Cataract Refract Surg. 2024;1;50(8):794-798.
- Berdahl JP, Grosinger L, Reed O. Visual Performance of a Novel Wavefront Shaping Extended Depth-of-Focus Intraocular Lens on a New Hydrophobic Acrylic Platform. J Cataract Refract Surg. 2025 Jul 21.
- Alcon data on file, 2025. REF-00720.
- Das KK, Werner L, Collins S, Hong X. In vitro and schematic model eye assessment of glare or positive dysphotopsia-type photic phenomena: Comparison of a new material IOL to other monofocal IOLs. J Cataract Refract Surg. 2019;45(2):219-227.
- Lane S, Collins S, Das KK, et al. Evaluation of intraocular lens mechanical stability. J Cataract Refract Surg. 2019;45(4):501-506.
- Dick HB, Conrad-Hengerer I, Schultz T. Intraindividual Capsular Bag Shrinkage Comparing Standard and Laser-Assisted Cataract Surgery. Journal of Refractive Surgery. 2014;30(4):228-233.
- Schartmuller D et al. Rotational stability and refractive outcomes of a new hydrophobic acrylic toric intraocular lens. Eye and Vision. 2024.